These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26487912)

  • 21. Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors.
    Lele AC; Raju A; Khambete MP; Ray MK; Rajan MG; Arkile MA; Jadhav NJ; Sarkar D; Degani MS
    ACS Med Chem Lett; 2015 Nov; 6(11):1140-4. PubMed ID: 26617968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
    Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
    Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Yogeeswari P; Sriram D; China A; Nagaraja V
    Eur J Med Chem; 2009 Jan; 44(1):345-58. PubMed ID: 18502542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
    Li D; Gao N; Zhu N; Lin Y; Li Y; Chen M; You X; Lu Y; Wan K; Jiang JD; Jiang W; Si S
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5178-81. PubMed ID: 26459210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
    Manjashetty TH; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
    Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics.
    Venugopala KN; Khedr MA; Pillay M; Nayak SK; Chandrashekharappa S; Aldhubiab BE; Harsha S; Attimard M; Odhav B
    J Biomol Struct Dyn; 2019 Apr; 37(7):1830-1842. PubMed ID: 29697293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancement of Imidazo[1,2-
    Moraski GC; Markley LD; Cramer J; Hipskind PA; Boshoff H; Bailey M; Alling T; Ollinger J; Parish T; Miller MJ
    ACS Med Chem Lett; 2013 Jul; 4(7):675-679. PubMed ID: 23930153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis.
    Kovalishyn V; Brovarets V; Blagodatnyi V; Kopernyk I; Hodyna D; Chumachenko S; Shablykin O; Kozachenko O; Vovk M; Barus M; Bratenko M; Metelytsia L
    Curr Drug Discov Technol; 2017; 14(1):25-38. PubMed ID: 27829331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid.
    Murugesan D; Palaniappan S; Perumal Y; Arnab C; Valakunja N; Sriram D
    Int J Antimicrob Agents; 2008 Apr; 31(4):337-44. PubMed ID: 18359434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel nicotine analogues with potential anti-mycobacterial activity.
    Gandhi PT; Athmaram TN; Arunkumar GR
    Bioorg Med Chem; 2016 Apr; 24(8):1637-47. PubMed ID: 26951892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: synthesis and biological evaluation.
    Ashok D; Chiranjeevi P; Kumar AV; Sarasija M; Krishna VS; Sriram D; Balasubramanian S
    RSC Adv; 2018 May; 8(30):16997-17007. PubMed ID: 35540499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.